Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Smokers and psychiatric comorbidities

Abstract : The prevalence of smoking in patients with psychiatric disorders is higher than the prevalence of smoking in general population. Smokers with psychiatric disorders are at a greater risk for medical morbidity and mortality, including chronic obstructive pulmonary disease, cardiovascular disease, and cancers, compared to those in the general population. Their life expectancies are considerably reduced (25 years). Tobacco-related illnesses are the leading cause of death in patients with psychiatric disorders. Smokers with psychiatric disorders report more severe withdrawal symptoms than those without psychiatric disorders. Withdrawal symptoms should be disentangled from those linked to psychiatric comorbidities. Approved pharmacotherapy, in particular nicotine replacement therapy, varenicline and bupropion, is recommended for nicotine-dependent smokers with psychiatric disorders. Quitting does not exacerbate pre-existing mental illness.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : samedi 26 février 2022 - 16:47:40
Dernière modification le : samedi 27 août 2022 - 14:27:58




Alain Dervaux, Xavier Laqueille. Smokers and psychiatric comorbidities. La Presse Médicale, Elsevier Masson, 2016, 45 (12, 1), pp.1133-1140. ⟨10.1016/j.lpm.2016.03.011⟩. ⟨hal-03590124⟩



Consultations de la notice